- Why Not Cap Medicines' MRPs At 16% Above Retailer Prices? Supreme Court Asks Live Law
- Supreme Court questions steep mark-ups on cancer drugs, calls pricing disparity ‘carnage’ The Hindu
- ‘Corporate hospitals don’t spare anyone,’ SC observes on exorbitant prices of cancer drugs Telegraph India
- 'This is carnage': SC questions huge gap in medicine prices, seeks 16% margin cap Deccan Herald
- Private hospitals functioning like industries, not service providers: Supreme Court Bar and Bench
Top stories - Google News
Why Not Cap Medicines' MRPs At 16% Above Retailer Prices? Supreme Court Asks - Live Law
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.